logo
Select company
Select metric
0%Buyback Yield
VS
Market
43
Sector
75
Industry
88
History
93
$ 2.35Close
$ 0.56 - $ 3.04 52-Week Range
Ticker Information

Ticker

SPRO

Company Name

SPERO THERAPEUTICS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

SPERO THERAPEUTICS INC - Buyback Yield Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

SPRO - Buyback Yield Historical data
DateBuyback YieldMarket CapitalizationNet Cash Flow - Issuance (Purchase) of Equity Shares
6/30/20250%$ 132.81M$ 0
3/31/20250%$ 38.58M$ 0
12/31/20240%$ 48.07M$ 0
9/30/20240%$ 68.15M$ 1K
6/30/2024-0.31%$ 72.43M$ 221K
3/31/2024-0.25%$ 87.46M$ 221K
12/31/2023-0.25%$ 89.42M$ 221K
9/30/2023-24.48%$ 58.83M$ 14.4M
6/30/2023-26.58%$ 76.41M$ 20.31M
3/31/2023-20.92%$ 100.94M$ 21.12M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • SPERO THERAPEUTICS INC's latest trailing twelve months (TTM) Buyback Yield stands at -18.58%.
  • Over the past 5 years, SPERO THERAPEUTICS INC's average Buyback Yield has been -19.87%.
  • The median Buyback Yield for SPERO THERAPEUTICS INC during this period was -13.92%
  • SPERO THERAPEUTICS INC reached its highest Buyback Yield over the past 5 years at 0%.
  • The lowest Buyback Yield recorded by SPERO THERAPEUTICS INC in the same timeframe -123.52%

SPERO THERAPEUTICS INC's Buyback Yield vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

Buyback Yield Benchmarks
CompanyBuyback Yield
CELU : CELULARITY INC -3.35%CSBR : CHAMPIONS ONCOLOGY INC -0.3%IVVD : INVIVYD INC -0.54%THTX : THERATECHNOLOGIES INC -PLX : PROTALIX BIOTHERAPEUTICS INC -10.57%BDTX : BLACK DIAMOND THERAPEUTICS INC 0.03%DOMH : DOMINARI HOLDINGS INC -19.42%ENTA : ENANTA PHARMACEUTICALS INC -0.1%CCCC : C4 THERAPEUTICS INC -5.54%EDIT : EDITAS MEDICINE INC -4.43%

Definition of Buyback Yield

[Calculation] The Buyback Yield is a ratio that calculates the difference between the trailing twelve-month share issuances and repurchases [NCFCommon] and divides it by the [MarketCap] of the company. A negative value indicates a dilution of shareholder value and might be considered as a warning sign.
(-1 * CF - Equity) / Market Cap
(=) Buyback Yield
Buyback Yield for SPERO THERAPEUTICS INC is calculated as follows: (-1 * CF - Equity [ $ 70.17M ]) / Market Cap [ $ 377.63M ]
(=) Buyback Yield [ -18.58% ]

SPRO - Buyback Yield, Last 5 years

-123.52%

Minimum

Jun 30, 2022

0%

Maximum

Dec 31, 2024

-19.87%

Average

-13.92%

Median

Buyback Yield Benchmark Analysis

The chart above depicts the distribution of Buyback Yield for companies in the Total Stock Market. The average Buyback Yield of the companies is 0.64% with a standard deviation of 2.7%.
The following table provides additional summary stats:
Buyback Yield in the Market:
filtered constituents3.28K
min-8.43%
max8.43%
average0.64%
median0.01%
std2.7%